title: Biological monitoring for occupational exposures to o-toluidine and aniline.
abstract: Epidemiological evidence that occupational exposure to o-toluidine and aniline is associated with an increased risk of bladder cancer led to efforts to identify biomarkers of workplace exposures to these aromatic amines. For the determination of o-toluidine and aniline in worker urine specimens, a method using high performance liquid chromatography (HPLC) followed by electrochemical detection was developed. The limits of detection were 0.6 microgram/l and 1.4 micrograms/l for o-toluidine and aniline, respectively. Recovery of o-toluidine and aniline from spiked urine averaged 86% and 93%, respectively, over a range of 4-100 micrograms/l. Reproducibility in the range 2-100 micrograms/l for analyses of split field samples was 13% (average RSD) for o-toluidine and 16% (average RSD) for aniline. Application of this method to pre- and post-shift samples collected from potentially exposed and unexposed workers indicated elevated concentrations of o-toluidine and aniline in urine from exposed workers. To develop methods for biomarkers of internal dose, o-toluidine binding to the blood proteins hemoglobin and albumin was investigated utilizing in-vivo (rodent) and in-vitro (hemoglobin and albumin) studies. Base-hydrolyzable protein adducts were analyzed by HPLC (fluorescence) and/or GC/electron capture (EC). The methods were compared for sample preparation requirements, selectivity and sensitivity. While the GC/EC method was more sensitive than HPLC, the presence of interfering peaks limited the utility of this approach. Results from these studies suggested that the HPLC method could be useful for determination of o-toluidine exposures in individuals acutely or chronically exposed to high levels.
authors.affiliation: Division of Biomedical and Behavioral Science, Centers for Disease Control and Prevention, Cincinnati, OH 45226.
authors.forename: A W
authors.initials: AW
authors.lastname: Teass
authors.forename: D G
authors.initials: DG
authors.lastname: DeBord
authors.forename: K K
authors.initials: KK
authors.lastname: Brown
authors.forename: K L
authors.initials: KL
authors.lastname: Cheever
authors.forename: L E
authors.initials: LE
authors.lastname: Stettler
authors.forename: R E
authors.initials: RE
authors.lastname: Savage
authors.forename: W W
authors.initials: WW
authors.lastname: Weigel
authors.forename: D
authors.initials: D
authors.lastname: Dankovic
authors.forename: E
authors.initials: E
authors.lastname: Ward
mesh_terms: D000814:Aniline Compounds / Q000032:analysis*; D000818:Animals; D015415:Biomarkers / Q000097:blood*; D002273:Carcinogens / Q000032:analysis* / Q000378:metabolism; D002849:Chromatography, Gas / Q000379:methods; D002851:Chromatography, High Pressure Liquid; D004784:Environmental Monitoring / Q000379:methods*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D016273:Occupational Exposure / Q000032:analysis*; D051381:Rats; D012680:Sensitivity and Specificity; D012709:Serum Albumin / Q000378:metabolism; D014052:Toluidines / Q000378:metabolism / Q000652:urine*
chemical_list: D000814:Aniline Compounds; D015415:Biomarkers; D002273:Carcinogens; D006454:Hemoglobins; D012709:Serum Albumin; D014052:Toluidines; C023622:2-toluidine; C023650:aniline